|
ANKRD36BP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.55780000010708E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.13180000319113E-08 |
| Normal-vs-Stage2 |
4.41479999999661E-05 |
| Normal-vs-Stage3 |
2.91879999947398E-07 |
| Normal-vs-Stage4 |
4.24889999994793E-06 |
| Stage1-vs-Stage2 |
8.674200E-01 |
| Stage1-vs-Stage3 |
6.912400E-01 |
| Stage1-vs-Stage4 |
6.145000E-01 |
| Stage2-vs-Stage3 |
9.093200E-01 |
| Stage2-vs-Stage4 |
7.970600E-01 |
| Stage3-vs-Stage4 |
8.563200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.1950999967425E-08 |
| Normal-vs-AfricanAmerican |
2.687900E-02 |
| Normal-vs-Asian |
5.0170999998933E-07 |
| Caucasian-vs-AfricanAmerican |
1.646200E-01 |
| Caucasian-vs-Asian |
3.045000E-01 |
| AfricanAmerican-vs-Asian |
4.284100E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.53209997413961E-09 |
| Normal-vs-Female |
2.82619999625311E-08 |
| Male-vs-Female |
2.198200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.47420000043519E-07 |
| Normal-vs-Age(41-60Yrs) |
6.42390000082926E-08 |
| Normal-vs-Age(61-80Yrs) |
2.47150000021179E-07 |
| Normal-vs-Age(81-100Yrs) |
1.014000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.193600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.884400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.140800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.122800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.425200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.592800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.145000E-01 |
| Classical-VS-Follicular |
3.581900E-02 |
| Classical-VS-Other |
8.807700E-02 |
| Classical-VS-Normal |
3.01279999948001E-07 |
| Tall-VS-Follicular |
9.179400E-01 |
| Tall-VS-Other |
2.723800E-01 |
| Tall-VS-Normal |
4.13980000000258E-05 |
| Follicular-VS-Other |
3.066200E-01 |
| Follicular-VS-Normal |
2.31910000092483E-08 |
| Other-VS-Normal |
1.097070E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.6481999622402E-09 |
| Normal-vs-N1 |
3.55779999905437E-08 |
| N0-vs-N1 |
2.358000E-01 |
|
|
